Hodgkin's Disease in the Setting of Human Immunodeficiency Virus Infection

References

• Goedert JJ, Coté TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, et al. Spectrum of AIDS-associated malignant disorder. Lancet 1998; 351: 1833–9.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. Classification system for human T-lymphotropic virus type III/lymphoadenopathy-associated virus infections. MMWR Morb Mortal Wkly Rep 1986; 35: 334–9.
   PubMedGoogle Scholar
• Levine AM. HIV-associated Hodgkin’s disease. Biologic and clinical aspects. Hematol Oncol Clin North Am 1996; 10: 1135–48.
   PubMed Web of Science ®Google Scholar
• Levine AM. Hodgkin’s disease in the setting of human immunodeficiency virus infection. Monogr Natl Cancer Inst 1998; 23: 37–42.
   Google Scholar
• Palella Jr FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853–60.
   PubMed Web of Science ®Google Scholar
• Ledergerber B, Telenti A, Effer M. Risk of HIV-related Kaposi’s sarcoma and non-Hodgkin’s lymphoma with potent antiretroviral therapy: prospective cohort study. Br Med J 1999; 319: 23–4.
   Google Scholar
• Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s disease. N Engl J Med 1998; 339: 1506–14.
   Google Scholar
• Davis S, Dahlberg S, Myers MH, Chen A, Steihnorm SC. Hodgkin’s disease in the United States: a comparison of patient characteristics and survival in the centralized cancer patient data system and the surveillance, epidemiology, and results program. J Natl Cancer Inst 1987; 78: 471–8.
   Google Scholar
• Marafioti T, Hummel M, Anagnostopoulos I, Foss HD, Falini B, Delsol G, et al. Origin of nodular lymphocyte-predominant variant Hodgkin’s disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med 1997; 337: 453–8.
   PubMed Web of Science ®Google Scholar
• Ohno T, Stribley JA, Wu G, Hinrichs SH, Weisenburger DD, Chan WC. Clonality in nodular lymphocyte-predominant Hodgkin’s disease. N Engl J Med 1997; 337: 459–65.
   PubMed Web of Science ®Google Scholar
• Marafioti T, Hummel M, Foss HD, Laumen H, Korbjuhn P, Anagnostopoulos I, et al. Hodgkin’s disease and Reed – Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000; 95: 1443–50.
   PubMed Web of Science ®Google Scholar
• Caussinus E, Meggetto F, Delsol G, Brousset P. Simultaneous occurrence of Epstein – Barr virus associated Hodgkin’s disease and HHV-8 related multicentric Castleman’s disease: a fortuitous event? J Clin Pathol 2001; 54: 790–1.
   PubMed Web of Science ®Google Scholar
• Audouin J, Diebold J, Pallesen G. Frequent expression of Epstein – Barr virus latent membrane protein-1 in tumour cells of Hodgkin’s disease in HIV-positive patients. J Pathol 1992; 167: 381–4.
   Google Scholar
• Ambinder RF. Epstein-Barr virus associated lymphoproliferations in the AIDS setting. Eur J Cancer 2001; 37: 1209–16.
   PubMed Web of Science ®Google Scholar
• Tirelli U, Spina M, Gaidano G, Vaccher E, Franceschi S, Carbone A. Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy. AIDS 2000; 14: 1675–88.
   PubMed Web of Science ®Google Scholar
• Hessol NA, Katz MH, Liu JY, Buchbinder SP, Rubino CJ, Holmberg SD. Increased incidence of Hodgkin’s disease in homosexual men with HIV infection. Ann Intern Med 1992; 117: 309–11.
   PubMed Web of Science ®Google Scholar
• Grulich AE, Wan X, Law MG, Coates M, Kaldor JM. Risk of cancer in people with AIDS. AIDS 1999; 13: 839–43.
   PubMed Web of Science ®Google Scholar
• Reynolds P, Saunders LD, Layefsky ME, Lemp GF. The spectrum of acquired immunodeficiency syndrome (AIDS)-as-sociated malignancies in San Francisco, 1980–1987. Am J Epidemiol 1993; 137: 19–30.
   PubMed Web of Science ®Google Scholar
• Rabkin CS, Yellin F. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1. J Natl Cancer Inst 1994; 86: 1711–6.
   PubMed Web of Science ®Google Scholar
• Franceschi S, Dal Maso L, Arniani S, Crosignani P, Vercelli M, Simonato L, et al. for the Cancer and AIDS Registry Linkage Study. Risk of cancer other than Kaposi’s sarcoma and non-Hodgkin’s lymphoma in persons with AIDS in Italy. Br J Cancer 1998; 78: 966–70.
   Google Scholar
• Grulich AE, Li Y, McDonald A, Correll PKL, Law MG, Kaldor JM. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 2002; 16: 1155–61.
   PubMed Web of Science ®Google Scholar
• Rapezzi D, Ugolini D, Ferraris AM, Racchi O, Gaetani GF. Histological subtypes of Hodgkin’s disease in the setting of HIV infection. Ann Hematol 2001; 80: 340–4.
   Google Scholar
• Uccini S, Monardo F, Stoppacciaro A, Gradilone A, Agliano AM, Faggioni A, et al. High frequency of Epstein – Barr virus genome detection in Hodgkin’s disease of HIV-positive patients. Int J Cancer 1990; 46: 581–5.
   PubMed Web of Science ®Google Scholar
• Dolcetti R, Zancai P, De Re V, Gloghini A, Bigoni B, Pivetta B, et al. Epstein – Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin’s disease. Blood 1997; 89: 1723–31.
   PubMed Web of Science ®Google Scholar
• Tsimberidou AM, Sarris AH, Medeiros LJ, Mesina O, Rodriguez MA, Hagemeiste FB, et al. Hodgkin’s disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome. Leuk Lymphoma 2001; 41: 535–44.
   PubMed Web of Science ®Google Scholar
• Poluri A, Shan KG, Carew JF, Shana AR, Har-El G, Lucente FE, Singh B. Hodgkin’s disease of the head and neck in human immunodeficiency virus-infected patients. Am J Otolaryngol 2002; 23: 12–6.
   Google Scholar
• Levine AM, Scadden DT, Zaia JA, Krishnan A. Hematologic aspects of HIV/AIDS, Hematology 2001; 463–478.
   Google Scholar
• Lyter DW, Bryant J, Thackeray R, Rinaldo CR, Kingsley LA. Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. J Clin Oncol 1995; 13: 2540–6.
   Google Scholar
• Levine AM, Li P, Cheung T, Tulpule A, Von Roenn J, Nathwani BN, Ratner L. Chemotherapy consisting of DTIC with G-CSF in HIV-infected patients with newly diagnosed Hodgkin’s disease: a prospective, multi-institutional AIDS Clinical Trials Group Study (ACTG 149). J Acquir Immune Defic Syndr 2000; 24: 444–50.
   Google Scholar
• Re A, Casari S, Cattaneo C, Facchetti F, Cadeo G, Carosi G, Rossi G. Hodgkin disease in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma. Cancer 2001; 92: 2739–45.
   Google Scholar
• Errante D, Gabarre J, Ridolfo AL, Rossi G, Nosari AM, Gisselbrecht C, et al. Hodgkin’s disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF. Ann Oncol 1999; 10: 189–95.
   PubMed Web of Science ®Google Scholar
• Spina M, Sandri S, Tirelli U. Hodgkin’s disease in HIV-infected individuals. Curr Opin Oncol 1999; 11: 522–6.
   Google Scholar
• Cossman J, Annunziata CM, Barash S, Staudt L, Dillon P, He WW, et al. Reed – Sternberg cell genome expression supports a B-cell lineage. Blood 1999; 94: 411–6.
   PubMed Web of Science ®Google Scholar
• Foss HD, Reusch R, Demel G, Lenz G, Anagnostopoulos I, Hummel M, Stein H. Frequent expression of the B-cell specific activator protein in Reed – Sternberg cells of classical Hodgkin’s disease provides further evidence for its B-cell origin. Blood 1999; 94: 3108–13.
   Google Scholar
• Spina M, Gabarre J, Fasan M. Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin’s disease and HIV infection. AIDS 2000; 14: 1457–8.
   Google Scholar
• Little RF, Yarchoan R, Wilson WH. Systemic chemotherapy for HIV-associated lymphoma in the era of highly active antiretroviral therapy. Curr Opin Oncol 2000; 12: 438–44.
   Google Scholar
• Gastaldi R, Martino P, Gentile G, Picardi V, De Propris MS, Pirillo MF, et al. Hodgkin’s disease in HIV-infected patients: report of eight cases usefully treated with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) plus granulocyte colony-stimulating factor. Ann Oncol 2002; 13: 1158–60.
   PubMed Web of Science ®Google Scholar